← Back to Search

Glycemic Management for High Blood Sugar in Surgical Patients

N/A

Waitlist Available

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Undergoing a surgical procedure, adults (older than 18 years of age), admitted to the hospital for more than 24 hours after their surgical procedure.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days

Awards & highlights

Study Summary

This trial will test whether the Perioperative Glycemic Management Pathway can reduce postoperative hyperglycemia and improve outcomes for surgical patients.

Who is the study for?

This trial is for adults over 18 who are undergoing surgery and will be in the hospital for more than a day afterward. It's designed to help those at risk of high blood sugar after their operation, including people with known or undiagnosed diabetes.Check my eligibility

What is being tested?

The trial tests a Perioperative Glycemic Management Pathway (PGMP) against usual care to see if it can better manage post-surgery blood sugar levels, shorten hospital stays, reduce readmissions, and save costs. The study involves multiple hospitals and uses a stepped-wedge design.See study design

What are the potential side effects?

Since this intervention focuses on managing blood sugar levels around the time of surgery rather than medication side effects per se, specific side effects aren't listed but may include risks associated with any changes in glycemic control.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult who will be in the hospital for more than a day after surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks after the index surgical procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks after the index surgical procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks after the index surgical procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Length of stay

Secondary outcome measures

Hypoglycemia

Readmissions

Other outcome measures

Surgical site infections

Trial Design

2Treatment groups

Active Control

Group I: Intervention: PGMPActive Control1 Intervention

Sites will implement a perioperative glycemic management pathway based on national guidelines and current evidence, with support of an implementation scientist team.

Group II: Non-intervention: usual careActive Control1 Intervention

Sites will perform usual perioperative glycemic management.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

791 Previous Clinical Trials

858,734 Total Patients Enrolled

Media Library

Perioperative glycemic management pathway Clinical Trial Eligibility Overview. Trial Name: NCT05036655 — N/A

High Blood Sugar Research Study Groups: Intervention: PGMP, Non-intervention: usual care

High Blood Sugar Clinical Trial 2023: Perioperative glycemic management pathway Highlights & Side Effects. Trial Name: NCT05036655 — N/A

Perioperative glycemic management pathway 2023 Treatment Timeline for Medical Study. Trial Name: NCT05036655 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open opportunities for volunteers to participate in this medical study?

"As of this moment, the clinical trial is in search for participants. It was initially advertised on 9/1/2021 and last modified on 5/16/2022 according to information found on clinicialtrials.gov."

Answered by AI

What is the magnitude of this clinical trial's participant pool?

"Affirmative. According to the information posted on clinicaltrials.gov, this medical study, which was initially made available on September 1st 2021 is actively enrolling patients. This experiment requires 10000 people from 2 distinct locations to be recruited."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PGMP for Alberta Surgical Patients

Shannon Ruzycki 2021. "PGMP for Alberta Surgical Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05036655.